← Back

Chemours Co

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Price · split & dividend adjusted
News & notes moving CC
CC

U.S. court approves New Jersey PFAS settlements totaling $2.5 billion

A federal judge approved more than $2.5 billion in settlements reached by New Jersey with DuPont, 3M, Chemours, and Corteva to resolve claims over PFAS pollution. The settlement with DuPont entities, valued at more than $2 billion, is the largest environmental settlement ever achieved by a single state, while the combined settlements with DuPont entities and 3M total approximately $2.5 billion. Chemours and Corteva were part of DuPont prior to spinoffs. The judge called the total value an impressive windfall given litigation risks and said the settlements were fair, reasonable, and in the public interest.
Seeking Alpha·19dRead more ▾
CC2

Chemours targets 2026 adjusted EBITDA of $775M to $825M and net leverage around 3.8x

Chemours outlined full-year 2026 adjusted EBITDA expectations of between $775 million and $825 million while targeting a net leverage ratio of approximately 3.8x by year-end. President and CEO Denise Dignam said second-quarter adjusted EBITDA exceeded expectations, supported by stronger operational performance, an improved product mix in Advanced Performance Materials, lower corporate costs, and pricing strength in Titanium Technologies. Senior Vice President and CFO Shane Hostetter guided third-quarter consolidated adjusted EBITDA to a range of $175 million to $205 million, with a sharp sequential decline in Thermal and Specialized Solutions due to aftermarket destocking, and set full-year net sales growth of 1% to 5% over 2025 alongside free cash flow conversion above 25%. Management also signaled openness to portfolio actions, with Dignam stating that no portfolio action is off the table where it can unlock a step change in shareholder value.
Seeking Alpha·21dRead more ▾
CC

Chemours declares $0.0875 per share quarterly dividend for third quarter of 2026

The Chemours Company announced that its Board of Directors declared a quarterly cash dividend of $0.0875 per share on its common stock for the third quarter of 2026. The dividend will be paid on September 15, 2026, to stockholders of record as of the close of business on August 14, 2026. Chemours is a global leader in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.
PR Newswire·22dRead more ▾
CC

Chemours Earnings Beat Signals and Valuation Shift Draw Investor Focus

Analysts have flagged Chemours' upcoming August 4 earnings report, citing a positive Earnings ESP and a top Zacks Rank as indicators of a potential earnings beat and attractive valuation versus peers. The combination of a strong value score and increasingly upbeat earnings expectations has sharpened investor focus on Chemours' fundamentals and its perceived undervaluation within the chemicals space. However, the company's investment narrative remains heavily influenced by PFAS liabilities, including a June 2026 settlement with the EPA and West Virginia regulators totaling US$112.5 million in penalties and mitigation funding, which adds clarity but also long-term cash commitments. Chemours' own projections target $6.8 billion in revenue and $1.3 billion in earnings by 2029, while some bullish analysts had already assumed revenue of about US$7.2 billion and earnings near US$1.4 billion before the recent callout. The stock's fair value has been estimated at $24.67, implying a 45% upside from its current price.
Simply Wall St·29dRead more ▾
CC

New York State Sues 3M, DuPont and Other Chemical Makers Over PFAS Contamination

New York State Attorney General Letitia James has sued chemical manufacturers including 3M and DuPont in state court over the sale of products containing toxic per- and polyfluoroalkyl substances, or PFAS. The lawsuit alleges that the defendant companies were aware of the toxicity of PFAS for years yet continued to use and sell them in consumer products, failed to adequately disclose the risks, and did not take effective measures to curb environmental contamination or mitigate harm. The defendants are 3M, DuPont, and DuPont spinoffs Chemours, Corteva, and EIDP. The state is seeking recovery of cleanup costs, proper warnings to consumers, damages and restitution, and civil penalties. PFAS are known as forever chemicals because they break down very slowly and have been linked to high cholesterol and kidney cancer. In May 2025, 3M agreed to a settlement of up to 450 million dollars over drinking water contamination in New Jersey, and Chemours reached a 450 million dollar settlement with the U.S. government in June of the same year.
Reuters·48dRead more ▾
CC

Chemours’ PFAS settlement includes $90 million in mitigation projects over 15 years

Chemours has reached a settlement with the U.S. Environmental Protection Agency and West Virginia authorities to resolve PFAS-related claims at several facilities. The company will pay a $22.5 million civil penalty over three years and commit $90 million to mitigation projects over 15 years. The agreement clarifies future environmental compliance obligations and expands off-site drinking water programs, which is expected to increase environmental reserves. This settlement addresses one of the largest outstanding U.S. environmental disputes for Chemours, reducing near-term legal exposure but embedding higher long-term mitigation spending that could weigh on free cash flow.
Simply Wall St·55dRead more ▾
Artificial Intelligence

Data Center Direct-to-Chip Coolants Market to Reach USD 1.30 Billion by 2032

The data center direct-to-chip coolants market is projected to grow from USD 0.18 billion in 2026 to USD 1.30 billion by 2032, at a compound annual growth rate of 38.6%. This expansion is driven by rapid advancements in artificial intelligence, machine learning, and high-performance computing, which increase server power densities and heat generation. Single-phase cooling technology using water-glycol mixtures is expected to hold the largest market share due to its operational simplicity and cost-effectiveness. The hyperscale data center segment will dominate, as high-density GPU configurations require efficient liquid cooling. Key players include Shell plc and The Chemours Company.
ResearchAndMarkets.com·56dRead more ▾
CC2impact 4

Chemours to pay $450 million in first federal PFAS settlement, North Carolina calls deal 'an insult'

The Trump administration has reached a multi-state settlement with Chemours over illegal PFAS discharges, marking the first time the federal government has settled with a manufacturer of these 'forever chemicals.' The agreement requires Chemours to pay an estimated $450 million in penalties and relief programs, including $22.5 million in civil penalties and $90 million over 15 years to reduce contamination in West Virginia, North Carolina, and New Jersey. The company will also spend $60 million on pollution-control systems at its West Virginia facility and $280 million to provide clean drinking water protection near its locations in West Virginia and New Jersey, while reducing PFAS releases in North Carolina pending an independent assessment. North Carolina's attorney general Jeff Jackson blasted the deal as a 'backroom deal' that does practically nothing to clean up the state's water, calling it 'an insult to the people of eastern North Carolina.' The settlement allows Chemours to continue manufacturing PFAS for commercial and military applications but aims to prevent further contamination.
Moneywise.com under the title·61dRead more ▾
CC2

Chemours shares surge 6.1% after PFAS settlement with U.S. EPA

Chemours shares jumped 6.1% to close at $21.17 after the company reached a comprehensive settlement with the U.S. EPA to resolve PFAS-related claims, reducing a significant regulatory overhang. The move was backed by solid volume and follows a 9.7% decline over the prior four weeks. Investors also reacted positively to the structured payment schedule, the resolution of additional litigation in West Virginia, and continued progress under the company's strategy to address legacy environmental liabilities. The company is expected to report quarterly earnings of $0.39 per share on revenues of $1.65 billion. Zacks Investment Research currently rates Chemours a Hold.
Zacks Investment Research·63dRead more ▾
CC

Chemours agrees to pay $22.5 million penalty and fund $90 million in PFAS mitigation projects under EPA settlement

Chemours has reached a settlement with the U.S. Environmental Protection Agency and the West Virginia Department of Environmental Protection to resolve claims related to PFAS discharges at its Washington Works, Fayetteville Works, and Chambers Works facilities. The company will pay a $22.5 million civil penalty over three years, with $15 million of that amount already accrued, and will fund $90 million in additional mitigation projects over the next 15 years to further reduce PFAS emissions and enhance off-site drinking water programs. The settlement also requires Chemours to expand its existing off-site drinking water programs in West Virginia, Ohio, and New Jersey, which is expected to increase its environmental reserves. The agreement, which remains subject to final court approval, provides greater clarity on future compliance requirements and supports the company's goal to reduce process emissions of fluorinated organic chemicals by 99% or more by 2030. Separately, Chemours resolved litigation with the West Virginia Rivers Coalition for less than $1 million over alleged Clean Water Act violations at its Washington Works site.
PR Newswire·63dRead more ▾